C[C@@H]1ON(C)[C@H]2C[C@H]3c4cc(N5CCN(C)CC5)ccc4CCN3C(=O)[C@@H]12
Orally active drug usually follows the rule of three, in which the molecular weight of a fragment is <300, the c Log P is ≤3, the number of hydrogen bond donors is ≤3 and the number of hydrogen bond acceptors is ≤3. The molecule meets rule of three or not?